Page last updated: 2024-10-28

haloperidol and Day Blindness

haloperidol has been researched along with Day Blindness in 5 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research Excerpts

ExcerptRelevanceReference
"Charles Bonnet syndrome is an underrecognized condition characterized by complex visual hallucinations, ocular problems causing visual deterioration and preserved cognitive status."5.35[Charles Bonnet syndrome: report of one case managed with haloperidol]. ( Franco, JG; Valencia, C, 2008)
"Charles Bonnet syndrome is an underrecognized condition characterized by complex visual hallucinations, ocular problems causing visual deterioration and preserved cognitive status."1.35[Charles Bonnet syndrome: report of one case managed with haloperidol]. ( Franco, JG; Valencia, C, 2008)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valencia, C1
Franco, JG1
Nguyen, H2
Le, C1
Wolter-Henseler, DK1
Man, PL1
Cocito, E1
Ambrosini, G1
Arata, A1
Bevilacqua, P1
Tortora, E1

Trials

1 trial available for haloperidol and Day Blindness

ArticleYear
Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:8

    Topics: Adult; Asthenia; Benperidol; Catatonia; Clinical Trials as Topic; Depression; Haloperidol; Humans; H

1970

Other Studies

4 other studies available for haloperidol and Day Blindness

ArticleYear
[Charles Bonnet syndrome: report of one case managed with haloperidol].
    Revista medica de Chile, 2008, Volume: 136, Issue:3

    Topics: Aged, 80 and over; Antipsychotic Agents; Diagnosis, Differential; Female; Hallucinations; Haloperido

2008
Charles Bonnet syndrome in an elderly patient concurrent with acute cerebellar infarction treated successfully with haloperidol.
    Journal of the American Geriatrics Society, 2011, Volume: 59, Issue:4

    Topics: Aged; Brain Infarction; Cerebellar Diseases; Dopamine Antagonists; Hallucinations; Haloperidol; Huma

2011
[Optical hallucinosis during benzodiazepine withdrawal in low-dose dependence].
    Psychiatrische Praxis, 1997, Volume: 24, Issue:6

    Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Hallucina

1997
Long-term effects of haloperidol.
    Diseases of the nervous system, 1973, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Back Pain; Basal Ganglia Diseases; Bipolar Disorder; Depression; Depressive Disor

1973